FDA Approves Keppra Injection
Keppra Injection is an intravenous formulation of levetiracetam providing an alternative for patients when oral administration is temporarily not feasible. Keppra Injection is indicated for use as adjunctive therapy in the treatment of partial-onset seizures in adults with epilepsy.Posted: July 2006
Related articles
- UCB Announces FDA Approval for Keppra in Infants and Children from One Month of Age with Partial Onset Seizures - January 25, 2012
- Keppra XR Approved in the U.S. - September 15, 2008
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
